Objective: To evaluate the efficacy and safety of bromelain to control pain and inflammation in cats undergoing ovariohysterectomy.
Animals: 30 client-owned cats undergoing ovariohysterectomy.
Procedures: In a randomized, blinded clinical study, cats were assigned to receive either oral bromelain suspension (40 mg/kg [18 mg/lb]; BG, n = 15) or placebo solution (0.